Estradiol/androgen receptors during aging: Microsomal distribution in human benign prostatic hypertrophy

Archives of Andrology

Volumn 51, Issue 1, 2005, Pages 49-53

  Salazar, Edith L ^a   Calzada, L ^b   Escontria, M ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Health Center (T III)   (Mexico)

^c Pub Hlth Serv of Distrito Federal   (Mexico)

Author keywords

Androgen receptor; Estradiol receptor; Microsomal distribution; Prostatic hypertrophy

Indexed keywords

ANDROGEN RECEPTOR; CHARCOAL; DEXTRAN; ESTRADIOL RECEPTOR;

ADULT; AGE; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MICROSOME; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; TISSUE GROWTH;

AGING; HUMANS; MALE; MICROSOMES; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN; RECEPTORS, ESTRADIOL;

EID: 11144229730     PISSN: 01485016     EISSN: None     Source Type: Journal    
DOI: 10.1080/014850190513021     Document Type: Article

References (18)

1. Barrack ER, Bujnovsky P, Walsh PC (1983): Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res 43:1107-1116.
2. Beaufay H (1974): Analytical study of microsomes and isolated subcellular membranes from rat liver. J Biochemical Methods 61:188-200.
3. Bernal A, Mercado E, et al. (1983): Microsomal and plasma membrane sialytransferase activity in rat epididymis. Arch Androl 11:33-38.
4. Calzada L, Martinez M, Salazar EL (1993): Evaluation of glaucolide receptor assays in human breast cancer tissues. Med Sci Res 23:645-646.
5. Calzada L, Taboada J, et al. (1998): Different affinities of tamoxifen binding sites in the estrogen receptor of breast cancer. Med Sci Res 26:829-230.
6. Calzada SL, Salazar EL, Pedrón NN (1995): Relationship between the outcome of tamoxifen therapy in ductal and lobular infiltrating breast cancer and estradiol and progesterone receptor values. Med Sci Res 23:771-772.
7. Calzada SL, Wusterhaus AH, Salazar EL (1995): Binding sites specific to steroid hormones on the plasma membrane of hormone-dependent breast tumors. Arch STD/HIV Res 9:189-196.
8. Hicks LL, Walsh PC (1979): A microassay for the measurement of androgen receptors in human prostatic tissue. Steroids 33:389-406.
9. Lowry OH, Rosebrough NJ, et al. (1951): Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
10. Lindberg O, Ernster L (1956): Determination of organic phosphorus compounds by phosphate analysis: Methods of Biochemical Analysis 3:1-22.
11. Quarmby VE, Yarbrough WG, et al. (1990): Autologous down-regulation of androgen receptor mRNA. Molecular Endocrinology 4:22-28.
12. Salazar EL, González JL, et al. (1996): Estrogen receptor in displastic and malignant cervical tissue: Expression, localisation and prognostic significance. Med Sci Res 24:523-524.
13. Sandberg AA (1975): Potential test systems for chemotherapeutic agents against prostatic cancer: Endocrine control of prostate, an international symposium in honor of DR. Charles Huggins. Vitam Horm 33:155-188.
14. Scatchard G (1949): The attraction of protein for small molecules and ions. Ann NY Acad Sci 193:265-275.
15. Song CS, Rubin W, et al. (1969): Plasma membranes of rat liver. J Cell Biol 41:124-132.
16. Voigt KD, Horst HJ, Kreig M (1975): Androgen metabolism in patients with benign hypertrophy. Vitam Horm 33:417-438.
17. Wernert N, Gerdes J, et al. (1988): Investigation of the estrogen (ER/ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunological basis. Virchows Archiv A Pathological Anatomy and Histopathology 412:387-391.
18. 3H-Methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinol 104:1007-1012.